Daniel Gradin, MD in Longview, WA - Medicare Ophthalmology

Daniel Gradin, MD is a medicare enrolled "Ophthalmology" physician in Longview, Washington. He went to Oregon Health Sciences University School Of Medicine and graduated in 1990 and has 34 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Oregon Health And Sciences University/university Medical Group and his current practice location is 600 Triangle Ctr, Suite 400, Longview, Washington. You can reach out to his office (for appointments etc.) via phone at (360) 423-0220.

Daniel Gradin is licensed to practice in Washington (license number MD60151712) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1275859399.

Contact Information

	Daniel Gradin, MD
	600 Triangle Ctr, Suite 400, Longview, WA 98632-4667
	(360) 423-0220
	(360) 423-0697

Physician's Profile

Full Name	Daniel Gradin
Gender	Male
Speciality	Ophthalmology
Experience	34 Years
Location	600 Triangle Ctr, Longview, Washington
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Daniel Gradin attended and graduated from Oregon Health Sciences University School Of Medicine in 1990

NPI Data:

NPI Number: 1275859399
Provider Enumeration Date: 04/14/2010
Last Update Date: 07/12/2019

Medicare PECOS Information:

PECOS PAC ID: 9739372384
Enrollment ID: I20101026001568

Medical Identifiers

Medical identifiers for Daniel Gradin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275859399	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	MD60151712 (Washington)	Primary
207W00000X	Ophthalmology	32843-020 (Wisconsin)	Secondary
207W00000X	Ophthalmology	MD150509 (Oregon)	Secondary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Peacehealth St John Medical Center	Longview, WA	Hospital
Peacehealth Southwest Medical Center	Vancouver, WA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Oregon Health And Sciences University/university Medical Group	4880760107	1485

News Archive

Novel method using big data tools shows promising routes for research

A group of researchers affiliated to the University of São Paulo - campus Ribeirão Preto, Brazil, used big data tools such as data mining and network analysis to develop a method to help scientists and companies identify technological routes, trends and partnerships in any knowledge area. For this purpose, it collected information from patent databases around the world.

Study shows how immune system reconstitutes itself following immune-depleting therapy

A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes.

Exposure of mBM-MSCs to VPA increases hepatic differentiation

Recent studies suggest that MSCs possess a greater differentiation potential than once thought and several hepatic differentiation protocols from bone marrow cells have been established. However, the incidence of bone marrow-derived hepatocytes was low. Moreover, a long culture period is needed in most cases.

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

"A rise in global funding for research into neglected diseases needs to be matched by a continued focus on delivering practical new ways to curb sickness in the developing world," according to the third annual report by the Global Funding of Innovation for Neglected Diseases released on Wednesday, Reuters reports.

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

Emmaus Medical, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of innovative and cost-effective treatments and therapies primarily for rare and orphan diseases, today announced it has completed all patient visits for its Phase 3 clinical trial for the treatment of sickle cell disease. Emmaus expects top-line data from the Phase 3 clinical trial to be available in the first quarter of 2014.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Daniel Gradin allows following entities to bill medicare on his behalf.

Entity Name	University Professional Services
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1881848307 PECOS PAC ID: 4880760107 Enrollment ID: O20081222000088

News Archive

Novel method using big data tools shows promising routes for research

Study shows how immune system reconstitutes itself following immune-depleting therapy

Exposure of mBM-MSCs to VPA increases hepatic differentiation

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Daniel Gradin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Daniel Gradin, MD 600 Triangle Ctr, Suite 400, Longview, WA 98632-4667 Ph: (360) 423-0220	Daniel Gradin, MD 600 Triangle Ctr, Suite 400, Longview, WA 98632-4667 Ph: (360) 423-0220

News Archive

Novel method using big data tools shows promising routes for research

Study shows how immune system reconstitutes itself following immune-depleting therapy

Exposure of mBM-MSCs to VPA increases hepatic differentiation

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

Ophthalmology Doctors in Longview, WA

Dr. James Ernest Hulbert, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 600 Triangle Ctr, Ste 400, Longview, WA 98632 Phone: 360-423-0220 Fax: 360-423-0697
Dong-wouk Park, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 Triangle Shopping Ctr Ste 400, Longview, WA 98632 Phone: 360-423-0220

Daniel Gradin, MD - Medicare Ophthalmology in Longview, WA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Novel method using big data tools shows promising routes for research

Study shows how immune system reconstitutes itself following immune-depleting therapy

Exposure of mBM-MSCs to VPA increases hepatic differentiation

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

Medicare Reassignments

Novel method using big data tools shows promising routes for research

Study shows how immune system reconstitutes itself following immune-depleting therapy

Exposure of mBM-MSCs to VPA increases hepatic differentiation

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Novel method using big data tools shows promising routes for research

Study shows how immune system reconstitutes itself following immune-depleting therapy

Exposure of mBM-MSCs to VPA increases hepatic differentiation

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

Ophthalmology Doctors in Longview, WA